At Aparito we’re involved in various projects across different study types including the development of novel digital endpoints, hybrid clinical trials and fully decentralised clinical trials.
Late Onset Pompe Disease (LOPD)
MPSIII (Sanfilippo Syndrome)
Ornithine transcarbamylase (OTC) deficiency
Cerebral Cavernous Malformation (CCM)
Pre-hab for Gynaecology Surgery
Neurodegenerative Disease in Adults
Digital Endpoint Development
Amyotrophic Lateral Sclerosis (ALS)
Primary Ciliary Dyskinesia (PCD)
Duchenne Muscular Dystrophy
Proof of Concept / Feasibility Study
Juvenile Idiopathic Arthritis (JIA)
Niemann-Pick Disease Type C (NPC)
Paediatric Refractory Epilepsy
Leber Congenital Amaurosis (LCA)
Late Onset GM2 Gangliosidosis
Neuropathic Gaucher Disease
Ready to get started?
Share your study requirements and unlock the potential of Atom5™ for your clinical trial!